Three medications have spasticity reduction as their primary indication: baclofen (Lioresal ®), dantrolene (Dantrium ®), and tizanidine (Zanaflex ®). These drugs represent the mainstays of ...

HealthDay News — In clinical practice guidelines jointly issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Jan. 21 in the Annals of Internal ...

Botox is a valuable tool in the management of multiple sclerosis (MS), addressing key symptoms such as spasticity, bladder dysfunction, and pain. Improving muscle function in MS and easing ...

THE Ministry of Health’s Disability and Rehabilitation Services, in collaboration with Northwell Health, hosted a one-day ...

Botulinum toxin therapy, particularly Botulinum neurotoxin type A (BoNT-A), has emerged as a prominent treatment option for managing spasticity ... in pain management, and establishing patient ...

Research trends indicate a growing interest in ESWT across various medical fields, with applications extending beyond spasticity management to include conditions like osteoarthritis and tendon ...

Spasticity is formally defined as a velocity-dependent increase in resistance to passive range of motion. It is a hallmark of neurological diseases that affect the central nervous system ...

Optimum management of spasticity is dependent on an understanding of its underlying physiology, an awareness of its natural history, an appreciation of the impact on the patient, and a comprehensive ...

Spasticity is a common sequela of multiple sclerosis (MS) that can cause pain, deformities, and impair movement. Transcranial magnetic stimulation (TMS) has been investigated for the treatment of ...

We established that a reliable ambulatory spasticity monitoring system that collates clinically meaningful data remotely would be useful in the management of this complex condition. This paper ...

Recommendations include using case management services at time of discharge ... botulinum toxin for focal spasticity; and a selective serotonin reuptake inhibitor or a serotonin norepinephrine ...